Summary
Clinical and epidemiological studies suggest that genetic factors may be involved in the etiology and pathogenesis of testicular germ-cell tumors (GCTs). Previous HLA studies have tried to support the concept of genetic anticipation of GCTs, however, the results obtained have been inconsistent. The reasons for the divergent results are mainly statistical problems, i.e., small patient populations, high numbers of antigens tested, and inhomogeneous study populations. In the present retrospective study, 52 patients with histologically pure seminoma were typed for their HLA-A, B, C, and DR antigens. Only BW41 proved to be significantly increased in frequency after correction for the number of antigens tested (chiQ=12.73;P=0.0005). HLA-DR1 was shown to be decreased, however, the difference was not significant. Regarding metastatic seminoma alone, there was a trend towards an increase of A29, BW41, and DR7. Our study gives only weak evidence for the participation of genetic factors in the pathogenesis of seminoma. The statistical trend of HLA association observed in metastatic seminoma deserves further concern as does the question of whether MHC class II antigens are also involved in the pathogenesis of testicular seminoma.
Similar content being viewed by others
Abbreviations
- EUC:
-
European Caucasian
- GCT:
-
Germ-cell tumor
- HLA:
-
Human leukocyte antigen
- MHC:
-
Major histocompatibility complex
References
Aiginger P, Kuzmits R, Kratzik C, Schwarz HP, Zielinski CC, Kühböck J, Mayr WR (1987) HLA-antigens and germ-cell tumours. Lancet I:276–277
Armitage P (1971) Statistical methods in medical research. Oxford, Blackwell
Baur MP, Danilovs JA (1980) Population analysis of HLA A, B, C, DR and other genetic markers. In: Terasaki PI (ed) Histocompatibility testing. UCLA Tissue Typing Lab., Los Angeles, Calif., pp 955–993
Carr BI, Bach FH (1979) Possible association between HLA-AW24 and metastatic testicular germ-cell tumours. Lancet I:1346–1347
DeWolf WC, Lange PH, Einarson ME, Yunis EJ (1979) HLA and testicular cancer. Nature 277:216–217
Dieckmann K-P, Boeckmann W, Brosig W, Jonas D, Bauer HW (1986) Bilateral testicular germ-cell tumors. Report of nine cases and review of the literature. Cancer 57:1254–1257
Dieckmann K-P, Becker T, Jonas D, Bauer HW (1987) Inheritance and testicular cancer. Oncology 44:367–377
Kuber W (1982) Testicular tumor and cryptorchidism. Eur Urol 8:280–283
Majsky A, Abrahamova J, Korinkova P, Bek V (1979) HLA-system and testicular germinative tumours. Oncology 36:228–231
Morse MJ, Whitmore WF (1986) Neoplasms of the testis. In: Walsh PC, Gittes RF, Perlmutter AD, Stamey TA (eds) Campbell's urology, 5th edn. Saunders, Philadelphia, pp 1535–1582
Oliver RTD, Stephenson CA, Parkinson MC, Forman D, Atkinson A, Bodmer J, Bodmer WF (1986) Germ-cell tumours of the testicle as a model of MHC influence on human malignancy. Lancet I:1506
Pollack MS, Vugrin D, Hennessy W, Herr HW, Dupont B, Whitmore WF (1982) HLA-antigens in patients with germ-cell cancers of the testis. Cancer Res 42:2470–2473
Svejgaard A, Jersild C, Staub-Nielsen W, Bodmer WF (1974) HLA-antigens and disease. Statistical and genetical considerations. Tissue Antigens 4:95–105
Vahlensieck W, Jaeger N (1985) Diagnostics and therapy of germinal testicular tumors. Urol Int 48:48–59
Van Rood JJ (1979) Microlymphocytotoxicity method. In: Ray JG (ed) Manual of tissue typing techniques. National Institutes of Health, Bethesda, pp 104–105
Von Hochstetter AR, Hedinger CE (1982) The differential diagnosis of testicular germ-cell tumors in theory and practice. Virchows Arch [A] 396:247–277
Author information
Authors and Affiliations
Additional information
Supported by Deutsche Krebsgesellschaft Landesverband Berlin
Rights and permissions
About this article
Cite this article
Dieckmann, K.P., von Keyserlingk, H.J. HLA association of testicular seminoma. Klin Wochenschr 66, 337–339 (1988). https://doi.org/10.1007/BF01735790
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01735790